rs200909197

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_172107.4(KCNQ2):​c.2266G>A​(p.Gly756Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000606 in 1,539,682 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G756G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00034 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00064 ( 0 hom. )

Consequence

KCNQ2
NM_172107.4 missense

Scores

1
4
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.161

Publications

1 publications found
Variant links:
Genes affected
KCNQ2 (HGNC:6296): (potassium voltage-gated channel subfamily Q member 2) The M channel is a slowly activating and deactivating potassium channel that plays a critical role in the regulation of neuronal excitability. The M channel is formed by the association of the protein encoded by this gene and a related protein encoded by the KCNQ3 gene, both integral membrane proteins. M channel currents are inhibited by M1 muscarinic acetylcholine receptors and activated by retigabine, a novel anti-convulsant drug. Defects in this gene are a cause of benign familial neonatal convulsions type 1 (BFNC), also known as epilepsy, benign neonatal type 1 (EBN1). At least five transcript variants encoding five different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
KCNQ2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 7
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • neonatal encephalopathy with non-epileptic myoclonus
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neonatal-onset developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • seizures, benign familial neonatal, 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • seizures, benign familial neonatal, 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • benign familial infantile epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • benign familial neonatal-infantile seizures
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • benign neonatal seizures
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP2
Missense variant in the KCNQ2 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 319 curated pathogenic missense variants (we use a threshold of 10). The gene has 78 curated benign missense variants. Gene score misZ: 4.0411 (above the threshold of 3.09). Trascript score misZ: 3.6968 (above the threshold of 3.09). GenCC associations: The gene is linked to benign familial infantile epilepsy, malignant migrating partial seizures of infancy, developmental and epileptic encephalopathy, 7, benign familial neonatal-infantile seizures, benign neonatal seizures, neonatal-onset developmental and epileptic encephalopathy, complex neurodevelopmental disorder, seizures, benign familial neonatal, 2, seizures, benign familial neonatal, 1, neonatal encephalopathy with non-epileptic myoclonus.
BP4
Computational evidence support a benign effect (MetaRNN=0.058703274).
BP6
Variant 20-63406997-C-T is Benign according to our data. Variant chr20-63406997-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 205849.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000335 (51/152210) while in subpopulation NFE AF = 0.000662 (45/68012). AF 95% confidence interval is 0.000508. There are 0 homozygotes in GnomAd4. There are 26 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 51 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_172107.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNQ2
NM_172107.4
MANE Select
c.2266G>Ap.Gly756Ser
missense
Exon 17 of 17NP_742105.1
KCNQ2
NM_001382235.1
c.2320G>Ap.Gly774Ser
missense
Exon 17 of 17NP_001369164.1
KCNQ2
NM_172106.3
c.2212G>Ap.Gly738Ser
missense
Exon 16 of 16NP_742104.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNQ2
ENST00000359125.7
TSL:1 MANE Select
c.2266G>Ap.Gly756Ser
missense
Exon 17 of 17ENSP00000352035.2
KCNQ2
ENST00000626839.2
TSL:1
c.2212G>Ap.Gly738Ser
missense
Exon 16 of 16ENSP00000486706.1
KCNQ2
ENST00000344462.8
TSL:1
c.2173G>Ap.Gly725Ser
missense
Exon 16 of 16ENSP00000339611.4

Frequencies

GnomAD3 genomes
AF:
0.000335
AC:
51
AN:
152210
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000662
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000259
AC:
38
AN:
146486
AF XY:
0.000210
show subpopulations
Gnomad AFR exome
AF:
0.000259
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000268
Gnomad NFE exome
AF:
0.000549
Gnomad OTH exome
AF:
0.000470
GnomAD4 exome
AF:
0.000636
AC:
882
AN:
1387472
Hom.:
0
Cov.:
36
AF XY:
0.000627
AC XY:
429
AN XY:
684338
show subpopulations
African (AFR)
AF:
0.000157
AC:
5
AN:
31774
American (AMR)
AF:
0.00
AC:
0
AN:
36424
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24920
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36396
South Asian (SAS)
AF:
0.0000747
AC:
6
AN:
80350
European-Finnish (FIN)
AF:
0.000190
AC:
7
AN:
36800
Middle Eastern (MID)
AF:
0.000183
AC:
1
AN:
5476
European-Non Finnish (NFE)
AF:
0.000776
AC:
836
AN:
1077636
Other (OTH)
AF:
0.000468
AC:
27
AN:
57696
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
59
118
176
235
294
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000335
AC:
51
AN:
152210
Hom.:
0
Cov.:
33
AF XY:
0.000350
AC XY:
26
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.000121
AC:
5
AN:
41458
American (AMR)
AF:
0.00
AC:
0
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4838
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000662
AC:
45
AN:
68012
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000287
Hom.:
0
Bravo
AF:
0.000321
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000558
AC:
4
ExAC
AF:
0.000261
AC:
29

ClinVar

ClinVar submissions as Germline

Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Developmental and epileptic encephalopathy (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
KCNQ2-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.060
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
3.8
DANN
Benign
0.87
DEOGEN2
Benign
0.0027
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.059
N
LIST_S2
Uncertain
0.87
D
M_CAP
Pathogenic
0.30
D
MetaRNN
Benign
0.059
T
MetaSVM
Uncertain
0.091
D
MutationAssessor
Benign
-0.23
N
PhyloP100
-0.16
PrimateAI
Uncertain
0.52
T
PROVEAN
Benign
-0.28
N
REVEL
Uncertain
0.39
Sift
Benign
1.0
T
Sift4G
Benign
0.84
T
Polyphen
0.0020
B
Vest4
0.041
MVP
0.63
MPC
0.63
ClinPred
0.0053
T
GERP RS
-4.1
Varity_R
0.096
gMVP
0.13
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200909197; hg19: chr20-62038350; API